Rumana Rafiq

2.0k total citations
8 papers, 759 citations indexed

About

Rumana Rafiq is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rumana Rafiq has authored 8 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rumana Rafiq's work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and BRCA gene mutations in cancer (2 papers). Rumana Rafiq is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and BRCA gene mutations in cancer (2 papers). Rumana Rafiq collaborates with scholars based in United Kingdom, Ireland and Germany. Rumana Rafiq's co-authors include Alan Ashworth, Christopher J. Lord, Rachel Brough, James Campbell, Asha Konde, Rowan Miller, Jessica Frankum, Helen N. Pemberton, Aditi Gulati and Chris T. Williamson and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Rumana Rafiq

7 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rumana Rafiq United Kingdom	7	562	425	122	114	88	8	759
Karina L. Conkrite United States	12	432 0.8×	262 0.6×	54 0.4×	62 0.5×	284 3.2×	17	754
Solrun J. Steine Norway	12	233 0.4×	263 0.6×	54 0.4×	62 0.5×	126 1.4×	25	526
Cristian P. Moiola Spain	18	421 0.7×	157 0.4×	37 0.3×	79 0.7×	285 3.2×	28	681
Thai H. Tran United States	18	494 0.9×	426 1.0×	69 0.6×	83 0.7×	155 1.8×	31	853
Shannon L. Gibson United States	7	426 0.8×	238 0.6×	39 0.3×	43 0.4×	194 2.2×	8	548
Julie R. Graham United States	12	326 0.6×	389 0.9×	30 0.2×	104 0.9×	139 1.6×	20	709
Hilda Martinez-Diaz United States	4	621 1.1×	253 0.6×	65 0.5×	75 0.7×	138 1.6×	4	755
Ritu Kulshrestha India	10	432 0.8×	119 0.3×	60 0.5×	95 0.8×	290 3.3×	35	647
Jyotsna M. Bhatavdekar India	15	329 0.6×	276 0.6×	148 1.2×	61 0.5×	157 1.8×	42	674
Isil Guney United States	10	610 1.1×	216 0.5×	40 0.3×	147 1.3×	191 2.2×	12	819

Countries citing papers authored by Rumana Rafiq

Since Specialization

Citations

This map shows the geographic impact of Rumana Rafiq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rumana Rafiq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rumana Rafiq more than expected).

Fields of papers citing papers by Rumana Rafiq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rumana Rafiq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rumana Rafiq. The network helps show where Rumana Rafiq may publish in the future.

Co-authorship network of co-authors of Rumana Rafiq

This figure shows the co-authorship network connecting the top 25 collaborators of Rumana Rafiq. A scholar is included among the top collaborators of Rumana Rafiq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rumana Rafiq. Rumana Rafiq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Rafiq, Rumana, et al.. (2020). The Impact of a Rotating Elective on Medical Students' Perception of Radiation Oncology. Cureus. 12(5). e7931–e7931.

2.

Menon, Malini, Richard Elliott, Rumana Rafiq, et al.. (2019). A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors. Scientific Reports. 9(1). 201–201. 39 indexed citations

3.

Dréan, Amy, Chris T. Williamson, Rachel Brough, et al.. (2017). Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers. Molecular Cancer Therapeutics. 16(9). 2022–2034. 58 indexed citations

4.

Pettitt, Stephen J., Dragomir B. Krastev, Helen N. Pemberton, et al.. (2017). Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells. Scientific Data. 4(1). 170020–170020. 13 indexed citations

5.

Williamson, Chris T., Rowan Miller, Helen N. Pemberton, et al.. (2016). ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A. Nature Communications. 7(1). 13837–13837. 270 indexed citations

6.

Bajrami, Ilirjana, Jessica Frankum, Asha Konde, et al.. (2013). Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity. Cancer Research. 74(1). 287–297. 279 indexed citations

7.

Pennington, Kyla, Jianhe Peng, Rumana Rafiq, et al.. (2009). Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. PROTEOMICS. 9(18). 4284–4297. 69 indexed citations

8.

Vasudev, Naveen, Janet E. Brown, Sarah Brown, et al.. (2008). Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival. Clinical Cancer Research. 14(6). 1775–1781. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact